Interferon-alpha induced changes in CEA expression in patients with CEA-producing tumours

Area of Science:

• Oncology
• Immunology
• Nuclear Medicine

Background:

• Enhanced antigen expression can improve tumor targeting with antibodies.
• Carcinoembryonic antigen (CEA) is a target antigen in certain tumors.
• Interferon-alpha (IFN-alpha) is investigated for its potential to modulate antigen expression.

Purpose of the Study:

• To analyze the effect of IFN-alpha on CEA expression and radioimmunoscintigraphy uptake in patients with CEA-producing tumors.
• To investigate the feasibility of using rhenium-186-labeled antibody fragments for future therapeutic studies.
• To evaluate the impact of IFN-alpha on antibody uptake and pharmacokinetics in tumor targeting.

Main Methods:

• Radioimmunoscintigraphy using 99mTc-CEA-Scan was performed on ten patients.
• Patients received IFN-alpha to assess its effect on CEA expression and antibody uptake.
• Pharmacokinetic analysis was conducted before and after IFN-alpha administration.

Main Results:

• IFN-alpha significantly increased antibody uptake by the tumor.
• Absolute antibody uptake remained low, with a mean increase from 0.475% to 0.562% of injected dose.
• No significant alterations in pharmacokinetics were observed after IFN-alpha treatment.

Conclusions:

• IFN-alpha can enhance tumor targeting by increasing antibody uptake.
• The observed increase in antibody uptake was of limited clinical significance for this patient group and antibody fragment.
• Further therapeutic studies with radiolabeled antibodies require careful consideration of efficacy.